Display Settings:

Format

Send to:

Choose Destination
    Trends Parasitol. 2004 Aug;20(8):355-8.

    Genomics meets transgenics in search of the elusive Cryptosporidium drug target.

    Source

    Center for Tropical and Emerging Global Diseases, University of Georgia, 623 Biological Sciences Building, Athens, GA 30602, USA. striepen@cb.uga.edu

    Abstract

    Cryptosporidium is an important pathogen of humans, and a challenging model for the laboratory. The parasite genome sequence, accessible through a comprehensive database, now provides exciting opportunities for urgently needed advances. Comparative genomics, combined with the genetic system in the related parasite Toxoplasma gondii, outlines a detailed Cryptosporidium parvum metabolic map and facilitates cell biological analyses. New targets for Cryptosporidium drug and vaccine development can be identified and validated based on this approach.

    PMID:
    15246316
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk